Clinical significance of anti-dense fine speckled 70 antibodies in dense fine speckled immunofluorescence positive patients, systemic autoimmune rheumatic diseases, and controls
Indian Journal of Medical Research · 01.07.2026 · 164 · 120-128
DOI: 10.25259/ijmr_2840_2025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Medical Research, online erschienen am 01.07.2026. Verfasst von Rammohan Mylavarapu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Nizam's Institute of Medical Sciences, Hyderabad, Telangana, India. Hauptthemen laut MEDLINE: Antibodies, Antinuclear, Rheumatic Diseases, Autoimmune Diseases, Transcription Factors. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background and objectives The dense fine speckled (DFS) anti-nuclear antibody (ANA) pattern, caused by anti-DFS70 antibodies, is often misunderstood due to its low association with systemic autoimmune rheumatic diseases (SARD) and presence in healthy individuals. Few studies suggest monospecific anti-DFS70 antibodies may exclude SARD. Given limited data from India, we aimed to assess the prevalence and clinical associations of anti-DFS70 antibodies in undefined disease, SARD, and controls.
Methods
Sera from patients with undefined disease and non-rheumatic disease controls were screened for DFS pattern during the evaluation for ANA by indirect immunofluorescence (IIF); positive samples were confirmed using anti-DFS70 ELISA and line immunoassay (LIA). SARD sera were tested by ANA IIF, ELISA, and LIA.
Results
DFS IIF pattern was observed in 0.25%, 0.57% and 0.4% of undefined disease referrals, SARD patients, and controls respectively. ELISA anti-DFS70 and LIA were positive in 90% of undefined disease sera, 15.4% vs . 5.7% of SARD cases, and 100% of controls, respectively. ELISA and LIA showed almost perfect agreement in undefined disease (κ= 0.861). In SARD group, anti-DFS70 ELISA positivity was predominantly observed in SLE ( P =0.003); higher ELISA optical density, higher systemic lupus erythematosus disease activity index (SLEDAI) scores ( P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Nizam's Institute of Medical Sciences, Hyderabad, Telangana, India.
- Department of Rheumatology and Clinical Immunology, Nizam's Institute of Medical Sciences, Hyderabad, Telangana, India.
- Department of Multi-disciplinary Research Unit (MRU), Nizam's Institute of Medical Sciences, Hyderabad, Telangana, India.
Zitieren
APA
Mylavarapu, R., Gavali, M., Puranam, K., Parejiya, B. K., & Rajasekhar, L. (2026). Clinical significance of anti-dense fine speckled 70 antibodies in dense fine speckled immunofluorescence positive patients, systemic autoimmune rheumatic diseases, and controls. Indian Journal of Medical Research, 164, 120-128. https://doi.org/10.25259/ijmr_2840_2025
Vancouver
Mylavarapu R, Gavali M, Puranam K, Parejiya BK, Rajasekhar L. Clinical significance of anti-dense fine speckled 70 antibodies in dense fine speckled immunofluorescence positive patients, systemic autoimmune rheumatic diseases, and controls. Indian Journal of Medical Research. 2026;164:120-128. doi:10.25259/ijmr_2840_2025
BibTeX
@article{Mylavarapu2026,
author = {Mylavarapu, Rammohan and Gavali, Meghna and Puranam, Kaushik and Parejiya, Bansi Kashyap and Rajasekhar, Liza},
title = {Clinical significance of anti-dense fine speckled 70 antibodies in dense fine speckled immunofluorescence positive patients, systemic autoimmune rheumatic diseases, and controls},
journal = {Indian Journal of Medical Research},
year = {2026},
volume = {164},
pages = {120--128},
doi = {10.25259/ijmr_2840_2025}
}
EUVIMED